These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 28402440)

  • 21. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
    Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males.
    Song M; Camargo MC; Weinstein SJ; Murphy G; Freedman ND; Koshiol J; Stolzenberg-Solomon RZ; Abnet CC; Männistö S; Albanes D; Rabkin CS
    Aliment Pharmacol Ther; 2018 Feb; 47(4):494-503. PubMed ID: 29243850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer.
    Aromaa A; Kosunen TU; Knekt P; Maatela J; Teppo L; Heinonen OP; Härkönen M; Hakama MK
    Am J Epidemiol; 1996 Jul; 144(2):142-9. PubMed ID: 8678045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma pepsinogens, antibodies against Helicobacter pylori, and risk of gastric cancer in the Shanghai Women's Health Study Cohort.
    Abnet CC; Zheng W; Ye W; Kamangar F; Ji BT; Persson C; Yang G; Li HL; Rothman N; Shu XO; Gao YT; Chow WH
    Br J Cancer; 2011 Apr; 104(9):1511-6. PubMed ID: 21407214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Helicobacter pylori CagA(+) infection in gastric cancer patients].
    Ławniczak M; Starzyńska T
    Pol Merkur Lekarski; 2002 Sep; 13(75):216-20. PubMed ID: 12474574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroreactivity to Helicobacter pylori antigens as a risk indicator of gastric cancer.
    Karami N; Talebkhan Y; Saberi S; Esmaeili M; Oghalaie A; Abdirad A; Mostafavi E; Hosseini ME; Mohagheghi MA; Mohammadi M
    Asian Pac J Cancer Prev; 2013; 14(3):1813-7. PubMed ID: 23679279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.
    Konturek PC; Konturek SJ; Bielanski W; Karczewska E; Pierzchalski P; Duda A; Starzynska T; Marlicz K; Popiela T; Hartwich A; Hahn EG
    J Physiol Pharmacol; 1999 Dec; 50(5):857-73. PubMed ID: 10695565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia.
    Ye W; Held M; Lagergren J; Engstrand L; Blot WJ; McLaughlin JK; Nyrén O
    J Natl Cancer Inst; 2004 Mar; 96(5):388-96. PubMed ID: 14996860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relative and attributable risks of cardia and non-cardia gastric cancer associated with Helicobacter pylori infection in China: a case-cohort study.
    Yang L; Kartsonaki C; Yao P; de Martel C; Plummer M; Chapman D; Guo Y; Clark S; Walters RG; Chen Y; Pei P; Lv J; Yu C; Jeske R; Waterboer T; Clifford GM; Franceschi S; Peto R; Hill M; Li L; Millwood IY; Chen Z;
    Lancet Public Health; 2021 Dec; 6(12):e888-e896. PubMed ID: 34838195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helicobacter pylori protein-specific antibodies and risk of colorectal cancer.
    Epplein M; Pawlita M; Michel A; Peek RM; Cai Q; Blot WJ
    Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):1964-74. PubMed ID: 24045925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No association between AICDA 7888 C/T polymorphism, Helicobacter pylori seropositivity, and the risk of atrophic gastritis and gastric cancer in Japanese.
    Hishida A; Matsuo K; Goto Y; Mitsuda Y; Hiraki A; Naito M; Wakai K; Tajima K; Hamajima N
    Gastric Cancer; 2010 Mar; 13(1):43-9. PubMed ID: 20373075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiplex serology of Helicobacter pylori antigens in detection of current infection and atrophic gastritis - A simple and cost-efficient method.
    Shafaie E; Saberi S; Esmaeili M; Karimi Z; Najafi S; Tashakoripoor M; Abdirad A; Hosseini ME; Mohagheghi MA; Khalaj V; Mohammadi M
    Microb Pathog; 2018 Jun; 119():137-144. PubMed ID: 29665437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Helicobacter pylori infection and gastric cardia cancer: a nested case-control study].
    Ren JS; Qiao YL
    Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):428-31. PubMed ID: 19024516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts.
    Helicobacter and Cancer Collaborative Group
    Gut; 2001 Sep; 49(3):347-53. PubMed ID: 11511555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serological response to Helicobacter pylori infection among Latin American populations with contrasting risks of gastric cancer.
    Camargo MC; Beltran M; Conde-Glez CJ; Harris PR; Michel A; Waterboer T; Carolina Flórez A; Torres J; Ferreccio C; Sampson JN; Pawlita M; Rabkin CS
    Int J Cancer; 2015 Dec; 137(12):3000-5. PubMed ID: 26178251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project.
    González CA; Megraud F; Buissonniere A; Lujan Barroso L; Agudo A; Duell EJ; Boutron-Ruault MC; Clavel-Chapelon F; Palli D; Krogh V; Mattiello A; Tumino R; Sacerdote C; Quirós JR; Sanchez-Cantalejo E; Navarro C; Barricarte A; Dorronsoro M; Khaw KT; Wareham N; Allen NE; Tsilidis KK; Bas Bueno-de-Mesquita H; Jeurnink SM; Numans ME; Peeters PHM; Lagiou P; Valanou E; Trichopoulou A; Kaaks R; Lukanova-McGregor A; Bergman MM; Boeing H; Manjer J; Lindkvist B; Stenling R; Hallmans G; Mortensen LM; Overvad K; Olsen A; Tjonneland A; Bakken K; Dumeaux V; Lund E; Jenab M; Romieu I; Michaud D; Mouw T; Carneiro F; Fenge C; Riboli E
    Ann Oncol; 2012 May; 23(5):1320-1324. PubMed ID: 21917738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Helicobacter pylori, pepsinogen, and gastric adenocarcinoma in Hawaii.
    Nomura AM; Kolonel LN; Miki K; Stemmermann GN; Wilkens LR; Goodman MT; Perez-Perez GI; Blaser MJ
    J Infect Dis; 2005 Jun; 191(12):2075-81. PubMed ID: 15897993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between Helicobacter pylori infection and the risk of gastric cancer in the Korean population: prospective case-controlled study.
    Chang WK; Kim HY; Kim DJ; Lee J; Park CK; Yoo JY; Kim HJ; Kim MK; Choi BY; Choi HS; Park KN
    J Gastroenterol; 2001 Dec; 36(12):816-22. PubMed ID: 11777209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stomach cancer risk in gastric cancer relatives: interaction between Helicobacter pylori infection and family history of gastric cancer for the risk of stomach cancer.
    Shin CM; Kim N; Yang HJ; Cho SI; Lee HS; Kim JS; Jung HC; Song IS
    J Clin Gastroenterol; 2010 Feb; 44(2):e34-9. PubMed ID: 19561529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation.
    Forman D; Newell DG; Fullerton F; Yarnell JW; Stacey AR; Wald N; Sitas F
    BMJ; 1991 Jun; 302(6788):1302-5. PubMed ID: 2059685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.